{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:39:20Z","timestamp":1761745160713},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100011002","name":"National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund","doi-asserted-by":"publisher","award":["81870902","81870902"],"award-info":[{"award-number":["81870902","81870902"]}],"id":[{"id":"10.13039\/501100011002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1038\/s41431-020-0578-z","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T16:02:53Z","timestamp":1581436973000},"page":"947-955","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cryptic exon activation causes dystrophinopathy in two Chinese families"],"prefix":"10.1038","volume":"28","author":[{"given":"Ming","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"key":"578_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH, Kunkel LM. Dystrophin\u2014the protein product of the Duchenne muscular-dystrophy locus. Cell. 1987;51:919\u201328.","journal-title":"Cell"},{"key":"578_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17:251\u201367.","journal-title":"Lancet Neurol"},{"key":"578_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10528-012-9554-9","volume":"51","author":"I Sansovi\u0107","year":"2013","unstructured":"Sansovi\u0107 I, Bari\u0161i\u0107 I, Dumi\u0107 K. Improved detection of deletions and duplications in the DMD gene using the multiplex ligation-dependent probe amplification (MLPA) method. Biochemical Genet. 2013;51:189\u2013201.","journal-title":"Biochemical Genet"},{"key":"578_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ana.24303","volume":"77","author":"A Ankala","year":"2015","unstructured":"Ankala A, da Silva C, Gualandi F, Ferlini A, Bean LJH, Collins C, et al. A comprehensive genomic approach for neuromuscular diseases gives a high diagnostic yield. Ann Neurol. 2015;77:206\u201314.","journal-title":"Ann Neurol"},{"key":"578_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1371\/journal.pbio.0050073","volume":"5","author":"YM Hua","year":"2007","unstructured":"Hua YM, Vickers TA, Baker BF, Bennett CF, Krainer AR. Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon. Plos Biol. 2007;5:729\u201344.","journal-title":"Plos Biol"},{"key":"578_CR6","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.nmd.2010.06.014","volume":"20","author":"E Mazzone","year":"2010","unstructured":"Mazzone E, Martinelli D, Berardinelli A, Messina S, D\u2019Amico A, Vasco G, et al. North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Neuromuscul Disord. 2010;20:712\u20136.","journal-title":"Neuromuscul Disord"},{"key":"578_CR7","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1093\/nar\/gkg616","volume":"31","author":"L Cartegni","year":"2003","unstructured":"Cartegni L, Wang JH, Zhu ZW, Zhang MQ, Krainer AR. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res. 2003;31:3568\u201371.","journal-title":"Nucleic Acids Res"},{"key":"578_CR8","doi-asserted-by":"crossref","unstructured":"Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67.","DOI":"10.1093\/nar\/gkp215"},{"key":"578_CR9","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","volume":"82","author":"YM Hua","year":"2008","unstructured":"Hua YM, Vickers TA, Okunola HL, Bennett CF, Krainer AR. Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. Am J Hum Genet. 2008;82:834\u201348.","journal-title":"Am J Hum Genet"},{"key":"578_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0092-8674(88)90065-7","volume":"54","author":"E Bonilla","year":"1988","unstructured":"Bonilla E, Samitt CE, Miranda AF, Hays AP, Salviati G, Dimauro S, et al. Duchenne muscular-dystrophy - deficiency of dystrophin at the muscle-cell surface. Cell. 1988;54:447\u201352.","journal-title":"Cell"},{"key":"578_CR11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.nmd.2017.04.003","volume":"27","author":"AK Zaum","year":"2017","unstructured":"Zaum AK, Stuve B, Gehrig A, Kolbel H, Schara U, Kress W, et al. Deep intronic variants introduce DMD pseudoexon in patient with muscular dystrophy. Neuromuscul Disord. 2017;27:631\u20134.","journal-title":"Neuromuscul Disord"},{"key":"578_CR12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/jhg.2016.7","volume":"61","author":"M Okubo","year":"2016","unstructured":"Okubo M, Minami N, Goto K, Goto Y, Noguchi S, Mitsuhashi S, et al. Genetic diagnosis of Duchenne\/Becker muscular dystrophy using next-generation sequencing: validation analysis of DMD mutations. J Hum Genet. 2016;61:483\u20139.","journal-title":"J Hum Genet"},{"key":"578_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0387-7604(98)00012-6","volume":"20","author":"M Ikezawa","year":"1998","unstructured":"Ikezawa M, Minami N, Takahashi M, Goto Y, Miike T, Nonaka I. Dystrophin gene analysis on 130 patients with Duchenne muscular dystrophy with a special reference to muscle mRNA analysis. Brain Dev. 1998;20:165\u20138.","journal-title":"Brain Dev"},{"key":"578_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/(SICI)1098-1004(1999)13:2<170::AID-HUMU12>3.0.CO;2-7","volume":"13","author":"M Ikezawa","year":"1999","unstructured":"Ikezawa M, Nishino I, Goto Y, Miike T, Nonaka I. Newly recognized exons induced by a splicing abnormality from an intronic mutation of the dystrophin gene resulting in Duchenne muscular dystrophy. Mutations in brief no. 213. Online. Hum Mutat. 1999;13:170.","journal-title":"Hum Mutat"},{"key":"578_CR15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/humu.10214","volume":"21","author":"S Tuffery-Giraud","year":"2003","unstructured":"Tuffery-Giraud S, Saquet C, Chambert S, Claustres M. Pseudoexon activation in the DMD gene as a novel mechanism for Becker muscular dystrophy. Hum Mutat. 2003;21:608\u201314.","journal-title":"Hum Mutat"},{"key":"578_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0960-8966(03)00169-X","volume":"14","author":"C Beroud","year":"2004","unstructured":"Beroud C, Carrie A, Beldjord C, Deburgrave N, Llense S, Carelle N, et al. Dystrophinopathy caused by mid-intronic substitutions activating cryptic exons in the DMD gene. Neuromuscul Disord. 2004;14:10\u20138.","journal-title":"Neuromuscul Disord"},{"key":"578_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ana.21290","volume":"63","author":"OL Gurvich","year":"2008","unstructured":"Gurvich OL, Tuohy TM, Howard MT, Finkel RS, Medne L, Anderson CB, et al. DMD pseudoexon mutations: Splicing efficiency, phenotype, and potential therapy. Ann Neurol. 2008;63:81\u20139.","journal-title":"Ann Neurol"},{"key":"578_CR18","unstructured":"Meregalli M, Maciotta S, Angeloni V, Torrente Y. Duchenne muscular dystrophy caused by a frame-shift mutation in the acceptor splice site of intron 26. Bmc Med. Genet. 2016;17:55."},{"key":"578_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/humu.21471","volume":"32","author":"MM Khelifi","year":"2011","unstructured":"Khelifi MM, Ishmukhametova A, Van Kien PK, Thorel D, Mechin B, Perelman S, et al. Pure intronic rearrangements leading to aberrant pseudoexon inclusion in dystrophinopathy: a new class of mutations? Hum Mutat. 2011;32:467\u201375.","journal-title":"Hum Mutat"},{"key":"578_CR20","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.nmd.2014.07.003","volume":"24","author":"M Trabelsi","year":"2014","unstructured":"Trabelsi M, Beugnet C, Deburgrave N, Commere V, Orhant L, Leturcq F, et al. When a mid-intronic variation of DMD gene creates an ESE site. Neuromuscul Disord. 2014;24:1111\u20137.","journal-title":"Neuromuscul Disord"},{"key":"578_CR21","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1039\/C4MD00184B","volume":"5","author":"VK Sharma","year":"2014","unstructured":"Sharma VK, Sharma RK, Singh SK. Antisense oligonucleotides: modifications and clinical trials. Medchemcomm. 2014;5:1454\u201371.","journal-title":"Medchemcomm"},{"key":"578_CR22","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s40265-016-0657-1","volume":"76","author":"YY Syed","year":"2016","unstructured":"Syed YY. Eteplirsen: First Global Approval. Drugs. 2016;76:1699\u2013704.","journal-title":"Drugs"},{"key":"578_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nn.4508","volume":"20","author":"DR Corey","year":"2017","unstructured":"Corey DR. Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy. Nat Neurosci. 2017;20:497\u20139.","journal-title":"Nat Neurosci"},{"key":"578_CR24","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s40265-018-0968-5","volume":"78","author":"SJ Keam","year":"2018","unstructured":"Keam SJ. Inotersen: First Global Approval. Drugs. 2018;78:1371\u20136.","journal-title":"Drugs"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-020-0578-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-020-0578-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-020-0578-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:01:27Z","timestamp":1684616487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-020-0578-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,11]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["578"],"URL":"https:\/\/doi.org\/10.1038\/s41431-020-0578-z","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,11]]},"assertion":[{"value":"7 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}